2
350
J. Chiron, J.-P. Galy
LETTER
(
3) (a) Chiron, J.; Galy, J. P. Z. Kristallogr. NCS 2002, 217,
87. (b) Sourdon, V.; Mazoyer, S.; Pique, V.; Galy, J. P.
Molecules 2001, 6, 673. (c) Filloux, N.; Galy, J.-P. Synlett
001, 1137.
2
2
(
(
(
4) Charmantray, F.; Duflos, A.; Lhomme, J.; Demeunynck, M.
J. Chem. Soc., Perkin Trans. 1 2001, 2962.
5) Taylor, R. C. In Electrophilic Aromatic Substitution; John
Wiley and Sons: Chichester, 1990, 219.
6) 4-Bromomethylacridine 6: Acridine 1 (1 g, 5.58 mmol)
was dissolved in H SO (20 mL) at 20 °C under N and
2
4
2
BMME 5 (1.05 g, 7,71 mmol) was added in one portion. The
mixture was maintained at 20 °C for 17 h then it was poured
into ice and stirred for 1 h. The precipitated was filtered off
and dissolved in CHCl . The organic layer was then dried
3
with MgSO , the solvent was removed under vacuo and the
4
resulting yellow solid was chromatographed (silica gel,
CHCl /cyclohexane, 7/3, v:v) to give 6 as a bright yellow
3
3
b
powder (466 mg, 31%). Mp 166 °C, lit. 165 °C.
7) Hess, F. K.; Stewart, P. B. J. Med. Chem. 1975, 18, 320.
8) 4,5-Bis(bromomethyl)acridine 7: Acridine 1 (2 g, 11.16
mmol) was heated in H SO (25 mL) to 50 °C under N and
Scheme 2 Bromomethylation of acridine.
(
(
2
4
2
BMME 5 (6.08 g, 44.64 mmol) was added in one portion.
The mixture was maintained at 50 °C for 12 h then it was
poured into ice and stirred for 1 h. The precipitated was
filtered off and dissolved in CHCl . The organic layer was
3
then dried with MgSO , the solvent was removed under
4
vacuo and the resulting yellow solid was recrystallized from
Scheme 3 a) CaCO , H O/Dioxane, reflux; b) RCOCl, DMAP,
3
2
dry Et O to give 7 as a bright yellow powder (2.49 g, 64%).
2
Et N, CH Cl .
3
2
2
1
Mp 156 °C. H NMR (300 MHz, CDCl ): d = 5.19 (s, 4 H),
3
7
.95 (dd, 1 H, J = 8 Hz), 8.37 (d, 1 H, J = 8 Hz), 8.50 (d, 1
1
3
H, J = 8 Hz), 9.91 (s, 1 H). C NMR (75 MHz, CDCl ): d =
27.01, 126.94, 127.59, 128.81, 131.55, 137.83, 139.45,
3
Table 1 Yields and Melting Points of Diester Derivatives
1
51.22. Anal. Calcd for C H Br N: C, 49.35; H, 3.04; N,
15 11 2
Moiety
R
Yield (%)
Mp (°C)
160
3.84. Found: C, 49.49; H, 3,03; N, 3.83.
(
9) (a) Georghiou, P. E.; Ashram, M.; Li, Z.; Chaulk, S. G. J.
Org. Chem. 1995, 60, 7284. (b) Smith, J. G.; Dibble, P. W.;
Sandborn, R. E. J. Org. Chem. 1986, 51, 3762. (c)Grissom,
J. W.; Klingberg, D.; Meyenburg, S.; Stallman, B. J. Org.
Chem. 1994, 59, 7876.
10) (5-{[(4-Chlorobenzoyl)oxy]methyl}-4-acridinyl)methyl
4-Chlorobenzoate 9b: A solution of 4-chlorobenzoyl
chloride (471 mg, 2.75 mmol) in CH Cl (10 mL) was added
a
b
c
d
e
f
Ph
79
79
82
81
67
32
65
42
4-Cl-C H
170
6
4
4-F-C H4
186
6
(
4-MeO-C H
199
6
4
2
2
4-Me N-C H
263
2
6
4
dropwise under N to a stirred solution of 7 (300 mg, 1.25
mmol), Et N (0.44 mL, 3.17 mmol) and DMAP (383 mg,
2
3
CH =CH
104
2
3.14 mmol) in CH Cl (20 mL) at 0 °C. After complete
2 2
–a
addition, the mixture was allowed to stand at r.t. for 6 h. The
organic layer was then washed with NaOH 1 N (2 × 35 mL),
dried with MgSO and the solvent was removed under
g
4-Cl-Prop
h
4-(Ph-N=N)-C H
218
6
4
4
vacuo. The resulting solid was purified by column
a
Compound 9g is an oil.
chromatography (silica gel, CH Cl /EtOAc, 99:1, v:v) to
2
2
1
give 9b as a yellow powder (515 mg, 81%). Mp 170 °C. H
NMR (300 MHz, CDCl , 25 °C): d = 6,21 (s, 4 H), 7.35 (m,
3
4
H), 7.53 (dd, J = 8.5, 6.9 Hz, 2 H), 7.84 (dd, J = 6.9, 0.8
advantage of the particular reactivity of position 4, respec-
tively 5, of acridine enhanced by protonation of the central
ring nitrogen. We also reported for the first time the 4,5-
bis(hydroxymethyl)acridine, which undergoes esterifica-
tion to give new 4,5-bisfunctional acridinic esters 9a–h
that are potential anticancer and antileishmanian drugs
Hz, 2 H), 7.97 (dd, J = 8.5, 0.8 Hz, 2 H), 8.02 (m, 4 H), 8.77
13
(
s, 1 H). C NMR (75 MHz, CDCl , 25 °C): d = 63.67,
3
125.50, 126.33, 128.26, 128.67, 128.73, 128.85, 131.10,
134.46, 136.18, 139.31, 146.13, 165.61. Anal. Calcd for
C H Cl NO : C, 67.58; H, 3.71; N, 2.71. Found: C, 67.45;
29 19
2
4
H, 3.70; N, 2.70.
(
11) (a) Read, M.; Harrison, R. J.; Romagnoli, B.; Tanious, F. A.;
Gowan, S. H.; Reszka, A. P.; Wilson, W. D.; Kelland, L. R.;
Neidle, S. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 4844.
(
Table 1).
(
b) Di Giorgio, C.; Delmas, F.; Filloux, N.; Robin, M.;
References
Seferian, L.; Azas, N.; Gasquet, M.; Costa, M.; Timon-
David, P.; Galy, J. P. Antimicrob. Agents Chemother. 2003,
47, 174.
(
(
1) Hess, F. K.; Cullen, E.; Grozinger, K. Tetrahedron Lett.
971, 28, 2591.
2) Chiron, J.; Galy, J. P. Heterocycles 2003, 60, 1653.
1
Synlett 2003, No. 15, 2349–2350 © Thieme Stuttgart · New York